Advanced statistical genomics, biomarker statistics, and computational biology could, therefore, help to speed up drug development, improve regulatory outcomes, provide support when working with ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...

Most work using AI in drug development intends to reduce the time and money it takes to bring one drug to market – currently 10 to 15 years and US$1 billion to $2 billion.

Developing a new drug takes between 10-to-15 years and $2.6 billion, as estimated by the Tufts Center for the Study of Drug Development, to get from conception to store shelves.

Molecular glues, tiny molecules that connect one protein to another, are promising targets for pharmaceutical research. By ...

Drug development occurs in a vibrant but fragile environment made up of many inhabitants. You can't fundamentally alter one without affecting all of the others.

Drug Development Is Slowing Down After Cuts at the FDA. Agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials. By . Jared S. Hopkins.

Oxana Iliach is a Senior Director of Regulatory Strategy at Certara (PA, USA), a biotech company that offers comprehensive solutions for transforming and accelerating drug development. In her spare ...

This alternative to outsourcing drug development can mean bringing new, and better, medicine to more people around the world quicker - an outcome too life-changing to ignore. References Bleys, J ...

Drug Development Is Slowing Down After Cuts at the FDA. Story by Jared S. Hopkins • 1mo. Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push ...